These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 1827945)
1. A novel mutation in the invariant AG of the acceptor splice site of intron 4 of the beta-hexosaminidase alpha-subunit gene in two unrelated American black GM2-gangliosidosis (Tay-Sachs disease) patients. Mules EH; Dowling CE; Petersen MB; Kazazian HH; Thomas GH Am J Hum Genet; 1991 Jun; 48(6):1181-5. PubMed ID: 1827945 [TBL] [Abstract][Full Text] [Related]
2. GM2-gangliosidosis B1 variant: analysis of beta-hexosaminidase alpha gene abnormalities in seven patients. Tanaka A; Ohno K; Sandhoff K; Maire I; Kolodny EH; Brown A; Suzuki K Am J Hum Genet; 1990 Feb; 46(2):329-39. PubMed ID: 2137287 [TBL] [Abstract][Full Text] [Related]
3. Six novel deleterious and three neutral mutations in the gene encoding the alpha-subunit of hexosaminidase A in non-Jewish individuals. Mules EH; Hayflick S; Miller CS; Reynolds LW; Thomas GH Am J Hum Genet; 1992 Apr; 50(4):834-41. PubMed ID: 1532289 [TBL] [Abstract][Full Text] [Related]
4. A splicing defect due to an exon-intron junctional mutation results in abnormal beta-hexosaminidase alpha chain mRNAs in Ashkenazi Jewish patients with Tay-Sachs disease. Ohno K; Suzuki K Biochem Biophys Res Commun; 1988 May; 153(1):463-9. PubMed ID: 2837213 [TBL] [Abstract][Full Text] [Related]
5. The major mutation among Japanese patients with infantile Tay-Sachs disease: a G-to-T transversion at the acceptor site of intron 5 of the beta-hexosaminidase alpha gene. Tanaka A; Sakuraba H; Isshiki G; Suzuki K Biochem Biophys Res Commun; 1993 Apr; 192(2):539-46. PubMed ID: 8484765 [TBL] [Abstract][Full Text] [Related]
6. The intron 7 donor splice site transition: a second Tay-Sachs disease mutation in French Canada. Hechtman P; Boulay B; De Braekeleer M; Andermann E; Melançon S; Larochelle J; Prevost C; Kaplan F Hum Genet; 1992 Dec; 90(4):402-6. PubMed ID: 1483696 [TBL] [Abstract][Full Text] [Related]
7. The mutations in Ashkenazi Jews with adult GM2 gangliosidosis, the adult form of Tay-Sachs disease. Navon R; Proia RL Science; 1989 Mar; 243(4897):1471-4. PubMed ID: 2522679 [TBL] [Abstract][Full Text] [Related]
8. Tay-Sachs disease: intron 7 splice junction mutation in two Portuguese patients. Ribeiro MG; Pinto R; Miranda MC; Suzuki K Biochim Biophys Acta; 1995 Jan; 1270(1):44-51. PubMed ID: 7827134 [TBL] [Abstract][Full Text] [Related]
9. Beta-hexosaminidase splice site mutation has a high frequency among non-Jewish Tay-Sachs disease carriers from the British Isles. Landels EC; Green PM; Ellis IH; Fensom AH; Bobrow M J Med Genet; 1992 Aug; 29(8):563-7. PubMed ID: 1387685 [TBL] [Abstract][Full Text] [Related]
10. Frequency of three Hex A mutant alleles among Jewish and non-Jewish carriers identified in a Tay-Sachs screening program. Paw BH; Tieu PT; Kaback MM; Lim J; Neufeld EF Am J Hum Genet; 1990 Oct; 47(4):698-705. PubMed ID: 2220809 [TBL] [Abstract][Full Text] [Related]
11. A "G" to "A" mutation at position -1 of a 5' splice site in a late infantile form of Tay-Sachs disease. Akli S; Chelly J; Mezard C; Gandy S; Kahn A; Poenaru L J Biol Chem; 1990 May; 265(13):7324-30. PubMed ID: 2139660 [TBL] [Abstract][Full Text] [Related]
12. A chronic GM2 gangliosidosis variant with a HEXA splicing defect: quantitation of HEXA mRNAs in normal and mutant fibroblasts. Fernandes MJ; Hechtman P; Boulay B; Kaplan F Eur J Hum Genet; 1997; 5(3):129-36. PubMed ID: 9272736 [TBL] [Abstract][Full Text] [Related]
13. A new point mutation in the beta-hexosaminidase alpha subunit gene responsible for infantile Tay-Sachs disease in a non-Jewish Caucasian patient (a Kpn mutant). Tanaka A; Punnett HH; Suzuki K Am J Hum Genet; 1990 Sep; 47(3):568-74. PubMed ID: 2144098 [TBL] [Abstract][Full Text] [Related]
14. Comparison of enzyme and DNA analysis in a Tay-Sachs disease carrier screening program. Yoo HW; Astrin KH; Desnick RJ J Korean Med Sci; 1993 Feb; 8(1):84-91. PubMed ID: 8343225 [TBL] [Abstract][Full Text] [Related]
15. The presence of two different infantile Tay-Sachs disease mutations in a Cajun population. McDowell GA; Mules EH; Fabacher P; Shapira E; Blitzer MG Am J Hum Genet; 1992 Nov; 51(5):1071-7. PubMed ID: 1307230 [TBL] [Abstract][Full Text] [Related]
17. Juvenile GM2 gangliosidosis caused by substitution of histidine for arginine at position 499 or 504 of the alpha-subunit of beta-hexosaminidase. Paw BH; Moskowitz SM; Uhrhammer N; Wright N; Kaback MM; Neufeld EF J Biol Chem; 1990 Jun; 265(16):9452-7. PubMed ID: 2140574 [TBL] [Abstract][Full Text] [Related]
18. Molecular basis of adult-onset and chronic GM2 gangliosidoses in patients of Ashkenazi Jewish origin: substitution of serine for glycine at position 269 of the alpha-subunit of beta-hexosaminidase. Paw BH; Kaback MM; Neufeld EF Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2413-7. PubMed ID: 2522660 [TBL] [Abstract][Full Text] [Related]
19. Multiple abnormal beta-hexosaminidase alpha chain mRNAs in a compound-heterozygous Ashkenazi Jewish patient with Tay-Sachs disease. Ohno K; Suzuki K J Biol Chem; 1988 Dec; 263(34):18563-7. PubMed ID: 2973464 [TBL] [Abstract][Full Text] [Related]
20. Ashkenazi-Jewish and non-Jewish adult GM2 gangliosidosis patients share a common genetic defect. Navon R; Kolodny EH; Mitsumoto H; Thomas GH; Proia RL Am J Hum Genet; 1990 Apr; 46(4):817-21. PubMed ID: 2278539 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]